Klin Farmakol Farm. 2016;30(4):28-30 | DOI: 10.36290/far.2016.032
Advanced breast cancer is up on rare cases generally incurable disease. Thanks to new knowledge about the biology of tumors,
which have brought to the treatment of new therapeutic options, an significant extension of survival for this diagnosis. Mainly
inclusion of anti HER2 treatments (trastuzumab, pertuzumab, trastuzumab emtansin, lapatinib), thanks to which the OS in patients
with HER2 gene amplification extended up to 56 months. But it is still an incurable illnes sand must, in addition to the efforts to
extend survival, think mainly to improve or at least maintain the quality of life of the patients.
Published: December 1, 2016 Show citation